Table 1 Baseline Characteristics
From: Effects of Ramadan fasting on platelet reactivity in diabetic patients treated with clopidogrel
Total n = 98 | |
|---|---|
Age years (mean ± SD) | 59.1 ± 10 |
Male gender; n (%) | 86 (87.7%) |
Cardiovascular risk factors n (%) | |
Dyslipidemia | 76 (77.5) |
Diabetes | 63 (64.3) |
Arterial hypertension | 61 (62.2) |
Smoking | 58 (59.2) |
Coronary artery disease | 48 (48.9) |
Number | |
2 | 60 (61.2) |
3 | 27 (27.5) |
≥ 4 | 11 (11.3) |
Treatment n (%) | |
Aspirin | 90 (91.8) |
Statins | 81 (82.6) |
Oral antidiabetics | 63 (64.2) |
Enzyme converting inhibitors | 59 (60.2) |
Beta-blockers | 42 (42.8) |
Diuretics | 20 (20.4) |
Angiotension receptor antagonists | 12 (12.2) |
Vitamin K antagonists | 5 (4.9) |
Clopidogrel indications | |
Coronary artery disease | 90 (91.8) |
Peripheral artery disease | 8 (8.2) |